The sodium-glucose co-transporter 2 inhibitor velagliflozin reduces hyperinsulinemia and prevents laminitis in insulin-dysregulated ponies - Meier, A; Reiche, D; De Laat, M; Pollitt, C; Walsh, D; Sillence, M (PLoS One, 2018)